Axa’s Alkami Technology ALKT Stock Holding History

Axa’s Portfolio ALKT Stock Details ALKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-406,677	Closed	-$8.16M	–	1181
2021 Q4	$8.16M	Buy	406,677 +103,548	+34%	+$2.65M	0.02%	546
2021 Q3	$7.48M	Buy	303,129 +103,129	+52%	+$3.07M	0.02%	579
2021 Q2	$7.13M	Buy	+200,000	New	+$7.33M	0.02%	612

Other funds holding ALKT

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

LPPF

Long Path Partners Fund Stamford, Connecticut $172M AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Axa's ALKT Position: Q1 2022 in Review

Axa sold out of Alkami Technology (ALKT) in Q1 2022, closing a stake of 406,677 shares — an estimated $8.16M sold.

Axa first reported a position in ALKT in Q2 2021 and held it in 3 quarters. The position peaked at $8.16M in Q4 2021. 82 funds tracked by Wall St. Rank hold ALKT as of Q1 2022.

Axa reported no remaining Alkami Technology position as of Q1 2022 after selling out during the quarter.
Axa sold 406,677 Alkami Technology shares in Q1 2022, an estimated $8.16M.
Axa first reported a position in Alkami Technology in Q2 2021 and held it in 3 quarters.
Axa's Alkami Technology position peaked at $8.16M in Q4 2021.
82 funds tracked by Wall St. Rank held Alkami Technology as of Q1 2022.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.